Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Interest Coverage Ratio for 4 consecutive years, with 0.36 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 88.7% to 0.36 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.35 through Dec 2025, up 39.05% year-over-year, with the annual reading at 2.35 for FY2025, 39.04% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 0.36 at Phathom Pharmaceuticals, up from 0.95 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 0.36 in Q4 2025, with the low at 13.74 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 4.45, with a median of 3.95 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio plummeted 31.98% in 2024, then skyrocketed 88.7% in 2025.
  • Over 4 years, Interest Coverage Ratio stood at 4.86 in 2022, then dropped by 10.41% to 5.36 in 2023, then soared by 40.41% to 3.2 in 2024, then surged by 88.7% to 0.36 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 0.36, 0.95, and 3.42 for Q4 2025, Q3 2025, and Q2 2025 respectively.